https://scholars.lib.ntu.edu.tw/handle/123456789/624128
標題: | Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study | 作者: | SZU-MIN HSIEH SHAN-CHWEN CHANG Cheng, Hao-Yuan Shih, Shin-Ru Lien, Chia En |
關鍵字: | Booster vaccination; COVID-19; MVC-COV1901; SARS-CoV-2; SARS-CoV-2 vaccine | 公開日期: | 八月-2022 | 出版社: | SPRINGER LONDON LTD | 卷: | 11 | 期: | 4 | 起(迄)頁: | 1493 | 來源出版物: | Infectious diseases and therapy | 摘要: | MVC-COV1901 is a protein subunit COVID-19 vaccine based on the stable prefusion spike protein S-2P adjuvanted with CpG 1018 and aluminum hydroxide. Interim results of a phase 2 clinical trial demonstrated favorable safety profile and immunogenicity and the vaccine has been authorized for use in Taiwan. However, waning antibody levels after immunization and variants of concern (VoC) could negatively impact vaccine-induced neutralization of virus. In this extension to the phase 1 clinical study we investigated a three-dose regimen of MVC-COV1901 for durability of antibody levels and virus neutralization capacity, including neutralization of the Omicron variant. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/624128 | ISSN: | 2193-8229 | DOI: | 10.1007/s40121-022-00652-6 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。